KR0146680B1 - 전립선 이상비대 치료용 스테로이드 유도체, 그의 제조방법 및 용도 - Google Patents

전립선 이상비대 치료용 스테로이드 유도체, 그의 제조방법 및 용도

Info

Publication number
KR0146680B1
KR0146680B1 KR1019930006652A KR930006652A KR0146680B1 KR 0146680 B1 KR0146680 B1 KR 0146680B1 KR 1019930006652 A KR1019930006652 A KR 1019930006652A KR 930006652 A KR930006652 A KR 930006652A KR 0146680 B1 KR0146680 B1 KR 0146680B1
Authority
KR
South Korea
Prior art keywords
group
carbon atoms
methyl
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019930006652A
Other languages
English (en)
Korean (ko)
Other versions
KR930021654A (ko
Inventor
고이찌 고지마
히또시 구라따
고끼 이시바시
히로요시 호리꼬시
다까까즈 하마다
Original Assignee
가와무라 요시부미
상꾜 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가와무라 요시부미, 상꾜 가부시끼가이샤 filed Critical 가와무라 요시부미
Publication of KR930021654A publication Critical patent/KR930021654A/ko
Application granted granted Critical
Publication of KR0146680B1 publication Critical patent/KR0146680B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019930006652A 1992-04-20 1993-04-20 전립선 이상비대 치료용 스테로이드 유도체, 그의 제조방법 및 용도 Expired - Fee Related KR0146680B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9981692 1992-04-20
JP92-99816 1992-04-20
JP32804392 1992-12-08
JP92-328043 1992-12-08

Publications (2)

Publication Number Publication Date
KR930021654A KR930021654A (ko) 1993-11-22
KR0146680B1 true KR0146680B1 (ko) 1998-08-01

Family

ID=26440917

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930006652A Expired - Fee Related KR0146680B1 (ko) 1992-04-20 1993-04-20 전립선 이상비대 치료용 스테로이드 유도체, 그의 제조방법 및 용도

Country Status (25)

Country Link
US (3) US5536714A (en:Method)
EP (2) EP0725074A3 (en:Method)
JP (1) JP2514778B2 (en:Method)
KR (1) KR0146680B1 (en:Method)
CN (2) CN1041095C (en:Method)
AT (1) ATE154937T1 (en:Method)
AU (1) AU656852B2 (en:Method)
CA (1) CA2094300C (en:Method)
CZ (2) CZ284206B6 (en:Method)
DE (1) DE69311837T2 (en:Method)
DK (1) DK0567271T3 (en:Method)
ES (1) ES2105108T3 (en:Method)
FI (1) FI931765A7 (en:Method)
GR (1) GR3024896T3 (en:Method)
HK (1) HK1000303A1 (en:Method)
HU (1) HU219579B (en:Method)
ID (1) ID18576A (en:Method)
IL (1) IL105478A (en:Method)
MX (1) MX9302300A (en:Method)
NO (1) NO304891B1 (en:Method)
NZ (1) NZ247449A (en:Method)
PH (1) PH31052A (en:Method)
RU (2) RU2097387C1 (en:Method)
TW (2) TW401420B (en:Method)
ZA (1) ZA932732B (en:Method)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1259419B (it) * 1991-05-24 1996-03-18 Erba Carlo Spa Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi
FI945105A0 (fi) * 1992-04-30 1994-10-31 Smithkline Beecham Corp 17alfa- ja 17beta-substituoitu estra-1,3,5(10)-trieeni-3-karboksyylihappo
GB9224148D0 (en) * 1992-11-18 1993-01-06 Smithkline Beecham Corp Compounds
US5641765A (en) * 1992-11-18 1997-06-24 Smithkline Beecham Corporation 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase
US5683995A (en) * 1992-11-18 1997-11-04 Smithkline Beecham Corporation 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors
ES2185666T3 (es) * 1993-09-03 2003-05-01 Smithkline Beecham Corp Formulacion estabilizada para comprimidos.
GB9324371D0 (en) * 1993-11-26 1994-01-12 Erba Carlo Spa Side chain fluoro substituted 3-carboxysteroids
GB9411103D0 (en) * 1994-06-03 1994-07-27 Smithkline Beecham Corp Compounds
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US5879711A (en) * 1997-11-07 1999-03-09 Sequeira; Joel A. Stable antiandrogenic gel composition
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US7258850B2 (en) * 1999-05-04 2007-08-21 Aradigm Corporation Methods and compositions for treating erectile dysfunction
US6428769B1 (en) * 1999-05-04 2002-08-06 Aradigm Corporation Acute testosterone administration
US7402577B2 (en) * 2001-10-03 2008-07-22 Merck & Co., Inc. Androstane 17-beta-carboxamides as androgen receptor modulators
AU2002361861A1 (en) * 2001-12-21 2003-07-30 Rhode Island Hospital SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
US20060148725A1 (en) * 2001-12-21 2006-07-06 The Miriam Hospital Selective 11beta HSD inhibitors and methods of use thereof
CA2524165A1 (en) * 2003-04-29 2004-11-11 The Miriam Hospital Selective testicular 11.beta.-hsd inhibitors and methods of use thereof
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
US7604386B2 (en) * 2005-11-18 2009-10-20 Federal-Mogul World Wide, Inc Lamp assembly having a socket made from high temperature plastic
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US8563728B2 (en) * 2009-07-09 2013-10-22 Aurobindo Pharma Ltd. Process for the preparation of Dutasteride
CN111362999B (zh) * 2020-03-16 2022-03-29 江苏联环药业股份有限公司 一种爱普列特杂质及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527030B2 (en) * 1978-04-13 1983-02-10 Merck & Co., Inc. 4-aza-17-substituted-5a-androstan-3-ones
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5137882A (en) * 1990-06-11 1992-08-11 Holt Dennis A Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
IE76452B1 (en) * 1990-10-29 1997-10-22 Sankyo Co Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use
AU1893492A (en) * 1991-04-17 1992-11-17 Merck & Co., Inc. Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
US5196411A (en) * 1991-08-16 1993-03-23 Merck & Co., Inc. 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
US5717088A (en) 1998-02-10
GR3024896T3 (en) 1998-01-30
EP0567271B1 (en) 1997-07-02
CZ67893A3 (en) 1994-01-19
PH31052A (en) 1998-02-03
EP0567271A3 (en) 1994-11-23
CZ283791B6 (cs) 1998-06-17
FI931765A0 (fi) 1993-04-19
RU2097387C1 (ru) 1997-11-27
RU2114861C1 (ru) 1998-07-10
TW238312B (en:Method) 1995-01-11
ES2105108T3 (es) 1997-10-16
EP0725074A3 (en) 1996-11-20
CA2094300A1 (en) 1993-10-21
MX9302300A (es) 1994-03-31
HUT64558A (en) 1994-01-28
KR930021654A (ko) 1993-11-22
CN1083070A (zh) 1994-03-02
CN1195666A (zh) 1998-10-14
ATE154937T1 (de) 1997-07-15
ZA932732B (en) 1993-10-28
EP0567271A2 (en) 1993-10-27
EP0725074A2 (en) 1996-08-07
HK1000303A1 (en) 1998-02-20
TW401420B (en) 2000-08-11
JP2514778B2 (ja) 1996-07-10
HU219579B (hu) 2001-05-28
NO931401L (no) 1993-10-21
NZ247449A (en) 1995-02-24
AU3698493A (en) 1993-10-21
IL105478A0 (en) 1993-08-18
CZ90097A3 (cs) 1998-07-15
CA2094300C (en) 2003-01-28
DE69311837T2 (de) 1998-02-12
DK0567271T3 (da) 1998-02-16
IL105478A (en) 1998-03-10
JPH06279487A (ja) 1994-10-04
NO931401D0 (no) 1993-04-16
CN1041095C (zh) 1998-12-09
US5536714A (en) 1996-07-16
CZ284206B6 (cs) 1998-09-16
AU656852B2 (en) 1995-02-16
FI931765L (fi) 1993-10-21
RU95101838A (ru) 1997-01-10
ID18576A (id) 1998-04-23
US5760025A (en) 1998-06-02
HU9301155D0 (en) 1993-07-28
NO304891B1 (no) 1999-03-01
DE69311837D1 (de) 1997-08-07
FI931765A7 (fi) 1993-10-21

Similar Documents

Publication Publication Date Title
EP0567271B1 (en) Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
HK1000303B (en) Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
EP0484094B1 (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use
DE69313921T2 (de) Neue 7-Beta-substituierte-4-Aza-5-Alpha-Cholestan-Onen als Inhibitoren 5-Alpha-Reduktases
RU2125061C1 (ru) ФТОРИРОВАННЫЕ ПРОИЗВОДНЫЕ 17β-ЗАМЕЩЕННОГО -4-АЗА-5α-АНДРОСТАН-3-ОНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
US5595996A (en) 7-substituted 4-aza cholanic acid derivatives and their use
EP0649431B1 (en) 17-amino substituted 4-azasteroid 5-alpha-reductase inhibitors
US5359071A (en) 15-substituted 4-azasteroids
CA2045867A1 (en) N-monosubstituted adamantyl/norbornanyl 17_beta-carbamides of 3-carboxy-androsts-3,5-dienes as testosterone 5 alpha-reductase inhibitors
AU695341B2 (en) Delta 16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors
US5698720A (en) Steroid derivatives
DE69606623T2 (de) Phenyl-substituierte 4-azasteroid-fluorderivate
CA2067265A1 (en) 17.beta.-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5.alpha.-reductase inhibitors
JPH0592989A (ja) テストステロン ５α−還元酵素阻害剤としての１７β−アシル−３−カルボキシ−アンドロスタ−３，５−ジエン類
JPH10501233A (ja) ５アルファレダクターゼの処理用ステロイド誘導体
JPH06316591A (ja) ステロイドのレダクターゼ抑制剤として選択される１７β−ポリアロイル−４−アザ−５α−アンドロスト−１−エン−３−オン
HK1005456B (en) Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20020506

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20030513

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20030513

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000